Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,372.60
16,642.90
20,184.00
15,803.00
20,880.00
20,373
Depreciation, Depletion & Amortization
326.50
838.60
1,662.00
2,375.00
2,165.00
2,114
Other Funds
5,794.90
4,648.30
3,989.00
1,222.00
10,583.00
611
Funds from Operations
6,251.20
11,156.00
14,533.00
12,206.00
8,132.00
17,648
Changes in Working Capital
1,823.30
1,181.60
934.00
5,645.00
5,432.00
5,096
Net Operating Cash Flow
8,074.50
12,337.70
13,599.00
17,851.00
13,564.00
12,552
Capital Expenditures
349.40
1,503.80
1,145.00
609.00
1,410.00
Sale of Fixed Assets & Businesses
-
312.00
7,495.00
-
-
Purchase/Sale of Investments
1,000.00
1,000.00
6,000.00
-
200.00
Net Investing Cash Flow
1,399.40
11,372.70
2,640.00
609.00
2,751.00
Issuance/Reduction of Debt, Net
3,597.00
452.20
116.00
1,459.00
4,953.00
Net Financing Cash Flow
58,113.60
195.10
10,144.00
8,503.00
16,338.00
Net Change in Cash
48,639.70
23,905.50
6,095.00
9,957.00
39.00
Free Cash Flow
8,331.80
13,712.00
14,607.00
18,341.00
14,848.00
Net Assets from Acquisitions
-
3,180.90
-
-
1,091.00
Change in Capital Stock
61,710.60
257.10
10,260.00
9,962.00
11,385.00
Exchange Rate Effect
-
-
-
-
16.00
Other Uses
50.00
6,000.00
-
-
-

About Cancer Genetics

View Profile
Address
Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Website http://www.cancergenetics.com
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.